Representative before the EPO

Technology company logo thumb
no operation time available
3 offices
Technology Company

We have observed 8 EP applications Lucie Viktoria Knight has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after August 22, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12724950

IMMUNOGENIC COMPOSITION

IPC classification:
A61K 39/08, C12N 15/62, C07K 14/33
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Lucie Viktoria Knight, GlaxoSmithKline
Status:
The patent has been granted
EP13801540

IMMUNOGENIC COMPOSITION

IPC classification:
A61K 39/08, C07K 14/33
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Lucie Viktoria Knight, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP13817931

IMMUNOGENIC COMPOSITION COMPRISING ELEMENTS OF C. DIFFICILE CDTB AND/OR CDTA PROTEINS

IPC classification:
A61K 39/08
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Lucie Viktoria Knight, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP14700370

MODIFIED ACE2 POLYPEPTIDES

IPC classification:
A61K 38/48, C12N 9/48
Applicant:
Apeiron Biologics AG
Agent:
Lucie Viktoria Knight, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP15704798

MICROBIOLOGICAL PROCESS

IPC classification:
A61K 31/445, C12R 1/465, C12P 17/12
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Lucie Viktoria Knight, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15824385

COMPOUNDS

IPC classification:
A61P 25/28, A61K 31/519, C07D 471/14
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Lucie Viktoria Knight, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15825267

COMPOUNDS

IPC classification:
A61P 9/10, A61P 25/28, A61K 31/527, A61K 31/519, C07D 513/12, C07D 491/20, C07D 487/20, C07D 487/14
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Lucie Viktoria Knight, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15762763

TRICYCLIC NITROGEN CONTAINING COMPOUNDS FOR TREATING NEISSERIA GONORRHOEA INFECTION

IPC classification:
A61P 31/04, A61K 31/554, A61K 31/542, A61K 31/5415, A61K 31/5383, A61K 31/538, A61K 31/4985, A61K 31/4375
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Lucie Viktoria Knight, GlaxoSmithKline
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature